MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/sj.jid.5700288

Медицинская библиотека · The Journal of investigative dermatology · 2006

Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome.

Hachem Jean-Pierre, Wagberg Fredrik, Schmuth Matthias, Crumrine Debra, Lissens Willy, Jayakumar Arumugam, Houben Evi, Mauro Theodora M, Leonardsson Göran, Brattsand Maria, Egelrud Torbjorn, Roseeuw Diane, Clayman Gary L, Feingold Kenneth R, Williams Mary L, Elias Peter M

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПоддержка правительства СШАПеревод в очереди

Аннотация

Mutations in the SPINK5 gene encoding the serine protease (SP) inhibitor, lymphoepithelial-Kazal-type 5 inhibitor (LEKTI), cause Netherton syndrome (NS), a life-threatening disease, owing to proteolysis of the stratum corneum (SC). We assessed here the basis for phenotypic variations in nine patients with "mild", "moderate", and "severe" NS. The magnitude of SP activation correlated with both the barrier defect and clinical severity, and inversely with residual LEKTI expression. LEKTI co-localizes within the SC with kallikreins 5 and 7 and inhibits both SP. The permeability barrier abnormality in NS was further linked to SC thinning and proteolysis of two lipid hydrolases (beta-glucocerebrosidase and acidic sphingomyelinase), with resultant disorganization of extracellular lamellar membranes. SC attenuation correlated with phenotype-dependent, SP activation, and loss of corneodesmosomes, owing to desmoglein (DSG)1 and desmocollin (DSC)1 degradation. Although excess SP activity extended into the nucleated layers in NS, degrading desmosomal mid-line structures with loss of DSG1/DSC1, the integrity of the nucleated epidermis appears to be maintained by compensatory upregulation of DSG3/DSC3. Maintenance of sufficient permeability barrier function for survival correlated with a compensatory acceleration of lamellar body secretion, providing a partial permeability barrier in NS. These studies provide a mechanistic basis for phenotypic variations in NS, and describe compensatory mechanisms that permit survival of NS patients in the face of unrelenting SP attack.

Для цитирования: Hachem Jean-Pierre, Wagberg Fredrik, Schmuth Matthias, Crumrine Debra, Lissens Willy, Jayakumar Arumugam, Houben Evi, Mauro Theodora M, Leonardsson Göran, Brattsand Maria, Egelrud Torbjorn, Roseeuw Diane, Clayman Gary L, Feingold Kenneth R, Williams Mary L, Elias Peter M. Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome.. The Journal of investigative dermatology. 2006. DOI: 10.1038/sj.jid.5700288.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.